About us

Apterna is pre-clinical biotechnology developing chemically synthesized RNA aptamers that bind to target molecules with outstanding specificity and affinity.

We are developing internalizing RNA aptamers that enable targeted delivery of various payloads including RNA, toxins, enzymes, chemotherapy agents, photodynamic molecules, radionuclides, and nanocarriers.

The company was founded by Professors John Rossi and Nagy Habib in 2011.

For more information please contact nagy@apterna.com